Form 8.3 - HORIZON THERAPEUTICS PLC

Barclays PLC

06 October 2023

 

FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1.				KEY INFORMATION
Name of person dealing (Note 1)				Barclays PLC.
Company dealt in				HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)				$0.001 ordinary shares
Date of dealing				05 Oct 2023
2.				INTERESTS AND SHORT POSITIONS
(a)	Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security:				$0.001 ordinary shares
				Long		Short
				Number	(%)	Number	(%)
(1)	Relevant securities			3,727,363	1.63%	60,635	0.03%
(2)	Derivatives (other than options):			49,520	0.02%	62,670	0.03%
(3)	Options and agreements to purchase/sell:			0	0.00%	0	0.00%
TOTAL:				3,776,883	1.65%	123,305	0.05%
(b)	Interests and short positions in relevant securities of the company, other than the class dealt in
Class of relevant security:				Long		Short
				Number	(%)	Number	(%)
(1)	Relevant securities
(2)	Derivatives (other than options):
(3)	Options and agreements to purchase/sell:
TOTAL:
3.				DEALINGS (Note 4)
(a)	Purchase and sales
Class of relevant Security			Purchase/sale			Number of securities	Price per unit
$0.001 ordinary shares			Purchase			100	116.2800 USD
$0.001 ordinary shares			Purchase			172	116.3250 USD
$0.001 ordinary shares			Purchase			250	116.3350 USD
$0.001 ordinary shares			Purchase			300	116.3200 USD
$0.001 ordinary shares			Purchase			547	116.2700 USD
$0.001 ordinary shares			Purchase			1,110	116.3195 USD
$0.001 ordinary shares			Purchase			1,200	116.2908 USD
$0.001 ordinary shares			Purchase			1,464	116.2734 USD
$0.001 ordinary shares			Purchase			2,136	116.3247 USD
$0.001 ordinary shares			Purchase			3,700	116.3033 USD
$0.001 ordinary shares			Purchase			4,215	116.2893 USD
$0.001 ordinary shares			Purchase			5,962	116.3050 USD
$0.001 ordinary shares			Purchase			20,818	116.3179 USD
$0.001 ordinary shares			Purchase			23,202	116.3104 USD
$0.001 ordinary shares			Purchase			23,887	116.3235 USD
$0.001 ordinary shares			Purchase			35,761	116.3023 USD
$0.001 ordinary shares			Purchase			36,470	116.2980 USD
$0.001 ordinary shares			Purchase			39,389	116.3225 USD
$0.001 ordinary shares			Purchase			58,704	116.3316 USD
$0.001 ordinary shares			Purchase			62,510	116.3300 USD
$0.001 ordinary shares			Purchase			67,937	116.3194 USD
$0.001 ordinary shares			Purchase			76,932	116.3500 USD
$0.001 ordinary shares			Purchase			112,475	116.3221 USD
$0.001 ordinary shares			Purchase			1,532,570	116.3017 USD
$0.001 ordinary shares			Purchase			17,911,156	116.3000 USD
$0.001 ordinary shares			Sale			5	116.3600 USD
$0.001 ordinary shares			Sale			100	116.3305 USD
$0.001 ordinary shares			Sale			100	116.2800 USD
$0.001 ordinary shares			Sale			100	116.3200 USD
$0.001 ordinary shares			Sale			161	116.3413 USD
$0.001 ordinary shares			Sale			400	116.3300 USD
$0.001 ordinary shares			Sale			408	116.3324 USD
$0.001 ordinary shares			Sale			443	116.3311 USD
$0.001 ordinary shares			Sale			669	116.3432 USD
$0.001 ordinary shares			Sale			1,300	116.3576 USD
$0.001 ordinary shares			Sale			1,300	116.3007 USD
$0.001 ordinary shares			Sale			1,324	116.3277 USD
$0.001 ordinary shares			Sale			1,990	116.3262 USD
$0.001 ordinary shares			Sale			6,071	116.3092 USD
$0.001 ordinary shares			Sale			6,947	116.2907 USD
$0.001 ordinary shares			Sale			15,336	116.3190 USD
$0.001 ordinary shares			Sale			20,258	116.3267 USD
$0.001 ordinary shares			Sale			20,667	116.3118 USD
$0.001 ordinary shares			Sale			21,744	116.3036 USD
$0.001 ordinary shares			Sale			42,246	116.3314 USD
$0.001 ordinary shares			Sale			57,379	116.3317 USD
$0.001 ordinary shares			Sale			75,632	116.3500 USD
$0.001 ordinary shares			Sale			1,838,582	116.3043 USD
$0.001 ordinary shares			Sale			17,537,546	116.3000 USD
(b)	Derivatives transactions (other than option transactions)
Product Name		Nature of transaction				Number of relevant securities	Price per unit
(c)	Options transactions in respect of existing securities
(i)	Writing, selling, purchasing or varying
Class  of  relevant  security	Product  description	Writing,  purchasing,  selling,  varying etc	Number  of  securities  to which  option  relates	Exercise  price  per unit	Type	Expiry  date	Option  money  paid/  received  per unit
(ii)	Exercising
Product name			Number of  securities			Exercise price  per unit
(d)	Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction				Details		Price per unit  (if applicable)
4.				OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing  and any other person relating to the voting rights of any relevant securities under any option  referred to on this form or relating to the voting rights or future acquisition or disposal of any  relevant securities to which any derivative referred to on this form is referenced. If none, this  should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				06 Oct 2023
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

 

END